Meridian Wealth Management LLC Sells 209 Shares of Humana Inc. (NYSE:HUM)

Meridian Wealth Management LLC decreased its position in Humana Inc. (NYSE:HUM) by 6.2% in the fourth quarter, HoldingsChannel.com reports. The institutional investor owned 3,177 shares of the insurance provider’s stock after selling 209 shares during the quarter. Meridian Wealth Management LLC’s holdings in Humana were worth $806,000 at the end of the most recent reporting period.

Other hedge funds also recently bought and sold shares of the company. Creative Financial Designs Inc. ADV lifted its position in Humana by 244.0% in the 3rd quarter. Creative Financial Designs Inc. ADV now owns 86 shares of the insurance provider’s stock worth $27,000 after buying an additional 61 shares during the last quarter. Ashton Thomas Securities LLC bought a new stake in Humana in the 3rd quarter worth approximately $31,000. FPC Investment Advisory Inc. bought a new stake in Humana in the 4th quarter worth approximately $27,000. Centricity Wealth Management LLC bought a new stake in Humana in the 4th quarter worth approximately $30,000. Finally, Atwood & Palmer Inc. lifted its position in Humana by 64.5% in the 4th quarter. Atwood & Palmer Inc. now owns 153 shares of the insurance provider’s stock worth $39,000 after buying an additional 60 shares during the last quarter. Institutional investors own 92.38% of the company’s stock.

Humana Trading Up 0.8 %

NYSE HUM opened at $263.74 on Wednesday. The company has a quick ratio of 1.76, a current ratio of 1.76 and a debt-to-equity ratio of 0.68. Humana Inc. has a twelve month low of $213.31 and a twelve month high of $406.46. The firm has a market capitalization of $31.82 billion, a PE ratio of 26.51, a P/E/G ratio of 2.05 and a beta of 0.57. The stock’s 50 day moving average is $271.40 and its 200 day moving average is $285.08.

Humana (NYSE:HUM) last released its quarterly earnings results on Tuesday, February 11th. The insurance provider reported ($2.16) earnings per share for the quarter, beating the consensus estimate of ($2.26) by $0.10. Humana had a return on equity of 11.70% and a net margin of 1.02%. Research analysts forecast that Humana Inc. will post 16.47 earnings per share for the current fiscal year.

Humana Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, April 25th. Investors of record on Friday, March 28th will be given a dividend of $0.885 per share. The ex-dividend date of this dividend is Friday, March 28th. This represents a $3.54 annualized dividend and a dividend yield of 1.34%. Humana’s dividend payout ratio is presently 35.58%.

Insiders Place Their Bets

In other Humana news, insider Timothy S. Huval sold 3,703 shares of the business’s stock in a transaction on Tuesday, December 31st. The stock was sold at an average price of $256.26, for a total value of $948,930.78. Following the sale, the insider now directly owns 8,181 shares of the company’s stock, valued at approximately $2,096,463.06. The trade was a 31.16 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Corporate insiders own 0.32% of the company’s stock.

Wall Street Analyst Weigh In

HUM has been the subject of a number of recent research reports. Royal Bank of Canada restated an “outperform” rating and issued a $283.00 target price on shares of Humana in a research report on Wednesday, February 12th. Bank of America raised Humana from an “underperform” rating to a “neutral” rating and lifted their price target for the stock from $247.00 to $308.00 in a research note on Wednesday, November 6th. Morgan Stanley decreased their price target on Humana from $301.00 to $285.00 and set an “equal weight” rating on the stock in a research note on Wednesday, February 12th. Piper Sandler lifted their price target on Humana from $270.00 to $288.00 and gave the stock a “neutral” rating in a research note on Wednesday, January 15th. Finally, Barclays lifted their price target on Humana from $255.00 to $270.00 and gave the stock an “equal weight” rating in a research note on Thursday, February 13th. Twenty research analysts have rated the stock with a hold rating and five have assigned a buy rating to the stock. Based on data from MarketBeat, the stock has an average rating of “Hold” and a consensus price target of $285.68.

Humana Company Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.